Guoji Yanke Zazhi (Feb 2017)

Clinical research of intravitreal injection of Conbercept combined with different methods in the treatment of neovascular glaucoma

  • Li-Ping Wang,
  • Han-Min Li

DOI
https://doi.org/10.3980/j.issn.1672-5123.2017.2.35
Journal volume & issue
Vol. 17, no. 2
pp. 332 – 334

Abstract

Read online

AIM:To observe the clinical effects of intravitreal injection of conbercept combined with complex trabeculectomy and panretinal photocoagulation(PRP)in the treatment of neovascular glaucoma.METHODS: Eleven patients(11 eyes)with neovascular glaucoma were injected with conbercept 0.50mg/0.05mL in vitreous chamber. Complex trabeculectomy was performed after the neovascularization dissipated, and PRP was performed in all cases at the right time. The follow-up time was 6mo. The vision, intraocular pressure(IOP)and complications were observed after complex trabeculectomy. RESULTS: The IOP were all decreased at 1wk, 1, 3 and 6mo after operation, and the difference was statistically significant(PCONCLUSION: Intravitreous injection of conbercept combined with complex trabeculectomy and PRP can control the IOP and preserve the visual function effectively in patients with neovascular glaucoma.

Keywords